Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan effects on inflammatory processes in the abdominal aortic aneurysm wall
NL-OMON43688Phase 2Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of telmisartan in abdominal aortic aneurysm (AAA), sponsored by Leiden University Medical Center. Primary endpoint: Exploratory pathway analysis of markers for inflammation, cell proliferation and matrix remodeling. Planned start Nov 2015; status: not yet recruiting.
02
Drugs
telmisartan
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NL-OMON43688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43688.